Responses
Late-breaking abstracts
Clinical trials in-progress
807 A multicenter open-label phase I/lb study of SO-C101 as monotherapy and in combination with pembrolizumab in patients with selected advanced/metastatic solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
